Treatment of septic encephalopathy and encephalitis – a critical appraisal

References

• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–810.
   PubMed Web of Science ®Google Scholar
• Ling H, Chen M, Dai J, et al. Evaluation of qSOFA combined with inflammatory mediators for diagnosing sepsis and predicting mortality among emergency department. Clin Chim Acta. 2023;544:117352. doi: 10.1016/j.cca.2023.117352
   PubMed Web of Science ®Google Scholar
• Zacharakis A, Ackermann K, Hughes C, et al. Combining C-reactive protein and quick sequential organ failure assessment (qSOFA) to improve prognostic accuracy for sepsis and mortality in adult inpatients: a systematic review. Health Sci Rep. 2023;6(4):e1229.
   PubMedGoogle Scholar
• Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001 Jul;29(7):1303–1310. doi: 10.1097/00003246-200107000-00002
   PubMed Web of Science ®Google Scholar
• Cizginer S, Marcantonio E, Vasunilashorn S, et al. The cognitive reserve model in the development of delirium: the successful aging after elective surgery study. J Geriatr Psychiatry Neurol. 2017;30(6):337–345. doi: 10.1177/0891988717732152
   PubMed Web of Science ®Google Scholar
• Schütze S, Drevets DA, Tauber SC, et al. Septic encephalopathy in the elderly – biomarkers of potential clinical utility. Front Cell Neurosci. 7 Sep 2023;17:2023. doi: 10.3389/fncel.2023.1238149
   Web of Science ®Google Scholar
• Lu X, Yang YM, Lu YQ. Immunosenescence: a critical factor associated with organ injury after sepsis. Front Immunol. 2022;13:917293. doi: 10.3389/fimmu.2022.917293
   PubMed Web of Science ®Google Scholar
• Perry VH, Newman TA, Cunningham C. The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci. 2003;4(2):103–112. doi: 10.1038/nrn1032
   PubMed Web of Science ®Google Scholar
• Werner H, Kuntsche J. Infection in the elderly–what is different? Z Gerontol Geriatr. 2000;33(5):350–356. doi: 10.1007/s003910070031
   PubMed Web of Science ®Google Scholar
• Peters van Ton AM, Meijer-van Leijsen EMC, Bergkamp MI, et al. Risk of dementia and structural brain changes following nonneurological infections during 9-year follow-up. Crit Care Med. 2022;50:554–564. doi: 10.1097/CCM.0000000000005313
   PubMed Web of Science ®Google Scholar
• Piva S, Bertoni M, Gitti N, et al. Neurological complications of sepsis. Curr Opin Crit Care. 2023;29(2):75–84.
   PubMed Web of Science ®Google Scholar
• Tauber SC, Eiffert H, Brück W, et al. Septic encephalopathy and septic encephalitis‬‬. Expert Rev Anti Infect Ther. 2017;15(2):121–132.
   PubMed Web of Science ®Google Scholar
• Tauber SC, Djukic M, Gossner J, et al. Sepsis-associated encephalopathy and septic encephalitis: an update. Expert Rev Anti Infect Ther. 2021;19(2):215–231.
   PubMed Web of Science ®Google Scholar
• Yan X, Yang K, Xiao Q, et al. Central role of microglia in sepsis-associated encephalopathy: from mechanism to therapy. Front Immunol. 2022;13:929316. doi: 10.3389/fimmu.2022.929316
   PubMed Web of Science ®Google Scholar
• Ji MH, Gao YZ, Shi CN, et al. Acute and long-term cognitive impairment following sepsis: mechanism and prevention. Expert Rev Neurother. 2023;23(10):931–943.
   PubMedGoogle Scholar
• Zoremba N, Coburn M. Acute confusional states in hospital. Dtsch Arztebl Int. 2019;116:101–106.
   PubMedGoogle Scholar
• Renner C, Jeitziner MM, Albert M, et al. Guideline on multimodal rehabilitation for patients with post-intensive care syndrome. Crit Care. 2023;27(1):301. doi: 10.1186/s13054-023-04569-5
   PubMed Web of Science ®Google Scholar
• Payne LE, Gagnon DJ, Riker RR, et al. Cefepime-induced neurotoxicity: a systematic review. Crit Care. 2017;21(1):276.
   PubMedGoogle Scholar
• Huang Q, Li J, Huang N, et al. Clinical characteristics and outcomes of antibiotic-associated encephalopathy in patients with end-stage kidney disease. Ren Fail. 2022;44(1):1708–1716.
   PubMed Web of Science ®Google Scholar
• Teng C, Frei CR. Delirium associations with antibiotics: a pharmacovigilance study of the FDA adverse event reporting system (FAERS). Drugs Real World Outcomes. 2022;9(1):23–29. doi: 10.1007/s40801-021-00268-1
   PubMedGoogle Scholar
• Bhattacharyya S, Darby RR, Raibagkar P, et al. Antibiotic-associated encephalopathy. Neurology. 2016;86(10):963–971. doi: 10.1212/WNL.0000000000002455
   PubMed Web of Science ®Google Scholar
• Bangert MK, Hasbun R. Neurological and psychiatric adverse effects of antimicrobials. CNS Drugs. 2019;33(8):727–753. doi: 10.1007/s40263-019-00649-9
   PubMed Web of Science ®Google Scholar
• Sørensen CG, Karlsson WK, Amin FM, et al. Metronidazole-induced encephalopathy: a systematic review. J Neurol. 2020;267(1):1–13.
   PubMed Web of Science ®Google Scholar
• Brouwer MC, Tunkel AR, McKhann GM, et al. Brain abscess. N Engl J Med. 2014;371(5):447–456.
   PubMed Web of Science ®Google Scholar
• Sonneville R, Ruimy R, Benzonana N, et al. An update on bacterial brain abscess in immunocompetent patients. Clin Microbiol Infect. 2017;23(9):614–620.
   PubMed Web of Science ®Google Scholar
• Yang E, Frazee BW. Infective endocarditis. Emerg Med Clin North Am. 2018;36(4):645–663. doi: 10.1016/j.emc.2018.06.002
   PubMed Web of Science ®Google Scholar
• Sursal T, Clare K, Feldstein E, et al. Significant increase in mortality and risk of acute ischemic stroke in infective endocarditis patients with subarachnoid hemorrhage secondary to mycotic aneurysms. J Neurol Sci. 2023;451:120670. doi: 10.1016/j.jns.2023.120670
   PubMedGoogle Scholar
• Rambaud T, de Montmollin E, Jaquet P, et al. Cerebrovascular complications and outcomes of critically ill adult patients with infective endocarditis. Ann Intensive Care. 2022;12(1):119. doi: 10.1186/s13613-022-01086-6
   PubMed Web of Science ®Google Scholar
• Shi H, Parikh NS, Esenwa C, et al. Neurological outcomes of patients with mycotic aneurysms in infective endocarditis. Neurohospitalist. 2021;11(1):5–11.
   PubMed Web of Science ®Google Scholar
• Pasina L, Colzani L, Cortesi L, et al. Relation between delirium and anticholinergic drug Burden in a cohort of hospitalized older patients: an observational study. Drugs Aging. 2019;36(1):85–91.
   PubMed Web of Science ®Google Scholar
• Drewas L, Ghadir H, Neef R, et al. Individual Pharmacotherapy Management (IPM) - I: a group-matched retrospective controlled clinical study on prevention of complicating delirium in the elderly trauma patients and identification of associated factors. BMC Geriatr. 2022;22(1):29. doi: 10.1186/s12877-021-02630-y
   PubMed Web of Science ®Google Scholar
• Djukic M, Krull J, Urbanczyk P, et al. Geriatric traumatological rounds in a primary care hospital. Unfallchirurgie. 2023;126(10):821–825. doi: 10.1007/s00113-023-01338-5
   PubMedGoogle Scholar
• Thanapluetiwong S, Ruangritchankul S, Sriwannopas O, et al. Efficacy of quetiapine for delirium prevention in hospitalized older medical patients: a randomized double-blind controlled trial. BMC Geriatr. 2021;21(1):215. doi: 10.1186/s12877-021-02160-7
   PubMed Web of Science ®Google Scholar
• Smit L, Slooter AJC, Devlin JW, et al. Efficacy of haloperidol to decrease the burden of delirium in adult critically ill patients: the EuRIDICE randomized clinical trial. Crit Care. 2023;27(1):413. doi: 10.1186/s13054-023-04692-3
   PubMed Web of Science ®Google Scholar
• Duan Y, Yang Y, Zhu W, et al. Melatonin intervention to prevent delirium in the intensive care units: a systematic review and meta-analysis of randomized controlled trials. Front Endocrinol. 2023;14:1191830. doi: 10.3389/fendo.2023.1191830
   PubMedGoogle Scholar
• Lange PW, Clayton-Chubb DI, Watson R, et al. Results from a double blinded, randomised, placebo-controlled, feasibility trial of melatonin for the treatment of delirium in older medical inpatients. Intern Med J. 2021;51(1):33–41.
   PubMed Web of Science ®Google Scholar
• Baumgartner L, Lam K, Lai J, et al. Effectiveness of melatonin for the prevention of intensive care unit delirium. Pharmacotherapy. 2019;39(3):280–287.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Gao F, Zhang S, et al. Prophylactic use of exogenous melatonin and melatonin receptor agonists to improve sleep and delirium in the intensive care units: a systematic review and meta-analysis of randomized controlled trials. Sleep Breath. 2019;23(4):1059–1070. doi: 10.1007/s11325-019-01831-5
   PubMed Web of Science ®Google Scholar
• Su X, Meng ZT, Wu XH, et al. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. Lancet. 2016;388(10054):1893–1902.
   PubMed Web of Science ®Google Scholar
• Li CJ, Wang BJ, Mu DL, et al. Randomized clinical trial of intraoperative dexmedetomidine to prevent delirium in the elderly undergoing major non-cardiac surgery. Br J Surg. 2020;107(2):e123–e132.
   PubMed Web of Science ®Google Scholar
• Burry L, Hutton B, Williamson DR, et al. Pharmacological interventions for the treatment of delirium in critically ill adults. Cochrane Database Syst Rev. 2019;9(9):CD011749. doi: 10.1002/14651858.CD011749.pub2
   PubMedGoogle Scholar
• Lewis K, Alshamsi F, Carayannopoulos KL, et al. Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials. Intensive care Med. 2022;48(7):811–840. doi: 10.1007/s00134-022-06712-2
   PubMed Web of Science ®Google Scholar
• Zhang Q, Huang Y, Gong C, et al. Dexmedetomidine attenuates inflammation and organ injury partially by upregulating Nur77 in sepsis. Immun Inflamm Dis. 2023;11(6):e883.
   PubMed Web of Science ®Google Scholar
• León-Salas B, Trujillo-Martín MM, Del Castillo LPM, et al. Pharmacologic interventions for prevention of delirium in hospitalized older people: a meta-analysis. Arch Gerontol Geriatr. 2020;90:104171. doi: 10.1016/j.archger.2020.104171
   PubMed Web of Science ®Google Scholar
• Yu A, Wu S, Zhang Z, et al. Cholinesterase inhibitors for the treatment of delirium in non-ICU settings. Cochrane Database Syst Rev. 2018;6(6):CD012494. doi: 10.1002/14651858.CD012494.pub2
   PubMedGoogle Scholar
• Vallabhajosyula S, Kanmanthareddy A, Erwin PJ, et al. Role of statins in delirium prevention in critical ill and cardiac surgery patients: a systematic review and meta-analysis. J Crit Care. 2017;37:189–196. doi: 10.1016/j.jcrc.2016.09.025
   PubMed Web of Science ®Google Scholar
• Crimi E, Rumana U, Ang DN, et al. Beneficial effects of prehospital use of statins in a large United States cohort of hospitalized coronavirus disease 2019 patients. J Cardiovasc Med (Hagerstown). 2023;24(3):172–183.
   PubMed Web of Science ®Google Scholar
• Liang B, Yang ST, Wei KK, et al. Statin use and mortality among patients hospitalized with sepsis: a retrospective cohort study within Southern California, 2008-2018. Crit Care Res Pract. 2022;2022:7127531. doi: 10.1155/2022/7127531
   PubMed Web of Science ®Google Scholar
• Xing H, Zhu S, Liu S, et al. Knowledge, attitudes and practices of ICU nurses regarding subsyndromal delirium among 20 hospitals in China: a descriptive cross-sectional survey. BMJ Open. 2022;12(9):e063821.
   PubMed Web of Science ®Google Scholar
• Ragheb J, Norcott A, Benn L, et al. Barriers to delirium screening and management during hospital admission: a qualitative analysis of inpatient nursing perspectives. BMC Health Serv Res. 2023;23(1):712.
   PubMed Web of Science ®Google Scholar
• Lee EY, Wilcox ME. Sleep in the intensive care unit. Curr Opin Pulm Med. 2022;28(6):515–521. doi: 10.1097/MCP.0000000000000912
   PubMed Web of Science ®Google Scholar
• Teodorczuk A, Reade MC, Graham FA. The Australian delirium clinical care standard: not just another brick in the wall. Age Ageing. 2023 Jun 1;52(6):afad078. doi: 10.1093/ageing/afad078
   PubMed Web of Science ®Google Scholar
• Matsuura Y, Ohno Y, Toyoshima M, et al. Effects of non-pharmacologic prevention on delirium in critically ill patients: a network meta-analysis. Nurs Crit Care. 2023;28(5):727–737. doi: 10.1111/nicc.12780
   PubMedGoogle Scholar
• Nau R, Eiffert H. Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis. Clin Microbiol Rev. 2002;15(1):95–110. doi: 10.1128/CMR.15.1.95-110.2002
   PubMed Web of Science ®Google Scholar
• Tauber SC, Nau R. Immunomodulatory properties of antibiotics. Curr Mol Pharmacol. 2008;1(1):68–79. doi: 10.2174/1874467210801010068.
   PubMedGoogle Scholar
• Nau R, Wellmer A, Soto A, et al. Rifampin reduces early mortality in experimental Streptococcus pneumoniae meningitis. J Infect Dis. 1999;179(6):1557–1560.
   PubMed Web of Science ®Google Scholar
• Azeh I, Gerber J, Wellmer A, et al. Protein synthesis inhibiting clindamycin improves outcome in a mouse model of Staphylococcus aureus sepsis compared with the cell wall active ceftriaxone. Crit Care Med. 2002;30(7):1560–1564.
   PubMed Web of Science ®Google Scholar
• Karlström A, Boyd KL, English BK, et al. Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza. J Infect Dis. 2009 Feb;1199(3):311–319. doi: 10.1086/596051
   Google Scholar
• Verma AK, Bauer C, Yajjala VK, et al. Linezolid attenuates lethal lung damage during postinfluenza methicillin-resistant staphylococcus aureus pneumonia. Infect Immun. 2019;87(10):e00538–19.
   PubMed Web of Science ®Google Scholar
• Cortes-Penfield N, Ryder JH. Should linezolid Replace clindamycin as the adjunctive antimicrobial of choice in group a streptococcal necrotizing soft tissue infection and toxic shock syndrome? a focused debate. Clin Infect Dis. 2023;76(2):346–350. doi: 10.1093/cid/ciac720
   PubMed Web of Science ®Google Scholar
• Patel A, Khande H, Periasamy H, et al. Immunomodulatory effect of doxycycline ameliorates systemic and pulmonary inflammation in a murine polymicrobial sepsis model. Inflammation. 2020;43(3):1035–1043.
   PubMed Web of Science ®Google Scholar
• Sauer A, Putensen C, Bode C. Immunomodulation by tetracyclines in the critically ill: an emerging treatment option? Crit Care. 2022;26(1):74. doi: 10.1186/s13054-022-03909-1
   PubMed Web of Science ®Google Scholar
• Jiang J, Tang B, Wang L, et al. Systemic LPS-induced microglial activation results in increased GABAergic tone: a mechanism of protection against neuroinflammation in the medial prefrontal cortex in mice. Brain Behav Immun. 2022;99:53–69. doi: 10.1016/j.bbi.2021.09.017
   PubMed Web of Science ®Google Scholar
• Yang G, Cao Y, Wang P, et al. Minocycline pretreatment prevents blood-brain barrier disruption in septic rats. J Surg Res. 2022;273:247–254. doi: 10.1016/j.jss.2022.01.021
   PubMed Web of Science ®Google Scholar
• Bi W, Cheng X, Zeng Z, et al. Rifampicin ameliorates lipopolysaccharide-induced cognitive and motor impairments via inhibition of the TLR4/MyD88/NF-κB signaling pathway in mice. Neurol Res. 2021;43(5):358–371.
   PubMed Web of Science ®Google Scholar
• Zhu L, Yuan Q, Zeng Z, et al. Rifampicin suppresses amyloid-β accumulation through enhancing autophagy in the hippocampus of a lipopolysaccharide-induced mouse model of cognitive decline. J Alzheimers Dis. 2021;79(3):1171–1184.
   PubMed Web of Science ®Google Scholar
• Iizuka T, Morimoto K, Sasaki Y, et al. Preventive effect of rifampicin on Alzheimer disease needs at least 450 mg daily for 1 year: an FDG-PET follow-up study. Dement Geriatr Cogn Dis Extra. 2017;7(2):204–214.
   PubMedGoogle Scholar
• Grandgirard D, Burri M, Agyeman P, et al. Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis. Antimicrob Agents Chemother. 2012;56(8):4289–4295.
   PubMed Web of Science ®Google Scholar
• Wald-Dickler N, Holtom P, Spellberg B. Busting the myth of “static vs cidal”: a systemic literature review. Clin Infect Dis. 2018;66(9):1470–1474. doi: 10.1093/cid/cix1127
   PubMed Web of Science ®Google Scholar
• Sekino N, Selim M, Shehadah A. Sepsis-associated brain injury: underlying mechanisms and potential therapeutic strategies for acute and long-term cognitive impairments. J Neuroinflammation. 2022;19(1):101. doi: 10.1186/s12974-022-02464-4
   PubMed Web of Science ®Google Scholar
• Spreer A, Lugert R, Stoltefaut V, et al. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis. Crit Care Med. 2009;37(7):2253–2258.
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu L, Liu L. Vitamin C as a treatment for organ failure in sepsis. Eur J Med Res. 2023;28(1):222. doi: 10.1186/s40001-023-01183-7
   PubMed Web of Science ®Google Scholar
• Consoli DC, Jesse JJ, Klimo KR, et al. A cecal slurry mouse model of sepsis leads to acute consumption of vitamin C in the brain. Nutrients. 2020;12(4):911.
   PubMed Web of Science ®Google Scholar
• Zhang N, Zhao W, Hu ZJ, et al. Protective effects and mechanisms of high-dose vitamin C on sepsis-associated cognitive impairment in rats. Sci Rep. 2021;11(1):14511.
   PubMed Web of Science ®Google Scholar
• Park JE, Shin TG, Jo IJ, et al. Impact of vitamin C and thiamine administration on delirium-free days in patients with septic shock. J Clin Med. 2020;9(1):193.
   PubMed Web of Science ®Google Scholar
• Lehnardt S, Massillon L, Follett P, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8514–8519. doi: 10.1073/pnas.1432609100
   PubMed Web of Science ®Google Scholar
• Iliev AI, Stringaris AK, Nau R, et al. Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). FASEB J. 2004;18(2):412–414.
   PubMedGoogle Scholar
• Swanson KV, Deng M, Ting JP. The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol. 2019;19(8):477–489. doi: 10.1038/s41577-019-0165-0
   PubMed Web of Science ®Google Scholar
• Sui DM, Xie Q, Yi WJ, et al. Resveratrol protects against sepsis-associated encephalopathy and inhibits the NLRP3/IL-1β axis in microglia. Mediators Inflamm. 2016;2016:1045657. doi: 10.1155/2016/1045657
   PubMed Web of Science ®Google Scholar
• Zhong X, Xie L, Yang X, et al. Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome. Mol Med. 2020;26(1):55.
   PubMed Web of Science ®Google Scholar
• Ait-Oufella H, Bourcier S, Lehoux S, et al. Microcirculatory disorders during septic shock. Curr Opin Crit Care. 2015;21(4):271–275.
   PubMed Web of Science ®Google Scholar
• Li J, Zeng X, Yang F, et al. Resveratrol: potential application in sepsis. Front Pharmacol. 2022;13:821358. doi: 10.3389/fphar.2022.821358
   PubMed Web of Science ®Google Scholar
• Bonfante S, Joaquim L, Fileti ME, et al. Stanniocalcin 1 inhibits the inflammatory response in microglia and protects against sepsis-associated encephalopathy. Neurotox Res. 2021;39(2):119–132.
   PubMed Web of Science ®Google Scholar
• Weberpals M, Hermes M, Hermann S, et al. NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits. J Neurosci. 2009;29(45):14177–14184.
   PubMed Web of Science ®Google Scholar
• Wu Q, Zhao Y, Chen X, et al. Propofol attenuates BV2 microglia inflammation via NMDA receptor inhibition. Can J Physiol Pharmacol. 2018;96(3):241–248.
   PubMed Web of Science ®Google Scholar
• Needham DM, Colantuoni E, Dinglas VD, et al. Rosuvastatin versus placebo for delirium in intensive care and subsequent cognitive impairment in patients with sepsis-associated acute respiratory distress syndrome: an ancillary study to a randomised controlled trial. Lancet Respir Med. 2016;4(3):203–212.
   PubMed Web of Science ®Google Scholar
• Yu SY, Ge ZZ, Xiang J, et al. Is rosuvastatin protective against sepsis-associated encephalopathy? A secondary analysis of the SAILS trial. World J Emerg Med. 2022;13(5):367–372. doi: 10.5847/wjem.j.1920-8642.2022.072
   PubMed Web of Science ®Google Scholar
• Liu Y, Given KS, Dickson EL, et al. Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo. Exp Neurol. 2019;318:32–41. doi: 10.1016/j.expneurol.2019.04.011
   PubMed Web of Science ®Google Scholar
• Chan AS, Katiyar V, Dy P, et al. Updates on the treatment of tenosynovial giant cell tumor. Hematol Oncol Stem Cell Ther. 2023;16(4):307–315.
   PubMedGoogle Scholar
• Zeren N, Afzal Z, Morgan S, et al. The chemokine receptor CCR1 mediates microglia stimulated glioma invasion. Int J Mol Sci. 2023;24(6):5136.
   PubMed Web of Science ®Google Scholar
• Shaw D, Abad R, Amin-Chowdhury Z, et al. Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS consortium. Lancet Digit Health. 2023;5(9):Se582–e593.
   Google Scholar
• Almog Y, Shefer A, Novack V, et al. Prior statin therapy is associated with a decreased rate of severe sepsis. Circulation. 2004;110(7):880–885.
   PubMed Web of Science ®Google Scholar
• Kruger P, Fitzsimmons K, Cook D, et al. Statin therapy is associated with fewer deaths in patients with bacteraemia. Intensive care Med. 2006;32(1):75–79.
   PubMed Web of Science ®Google Scholar
• Thomsen RW, Hundborg HH, Johnsen SP, et al. Statin use and mortality within 180 days after bacteremia: a population-based cohort study. Crit Care Med. 2006;34(4):1080–1086.
   PubMed Web of Science ®Google Scholar
• Kopterides P, Falagas ME. Statins for sepsis: a critical and updated review. Clin Microbiol Infect. 2009;15(4):325–334. doi: 10.1111/j.1469-0691.2009.02750.x
   PubMed Web of Science ®Google Scholar
• Pertzov B, Eliakim-Raz N, Atamna H, et al. Hydroxymethylglutaryl-CoA reductase inhibitors (statins) for the treatment of sepsis in adults – a systematic review and meta-analysis. Clin Microbiol Infect. 2019;25(3):280–289.
   PubMed Web of Science ®Google Scholar
• Hu SY, Hsieh MS, Lin TC, et al. Statins improve the long-term prognosis in patients who have survived sepsis: a nationwide cohort study in Taiwan (STROBE complaint). Medicine (Baltimore). 2019;98(17):e15253.
   PubMed Web of Science ®Google Scholar
• Lee CC, Lee MTG, Hsu TC, et al. A population-based cohort study on the drug-specific effect of statins on sepsis outcome. Chest. 2018;153(4):805–815. doi: 10.1016/j.chest.2017.09.024
   PubMed Web of Science ®Google Scholar